Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-007 Topical Gel for High-Grade Cervical Dysplasia (TG-003)
NCT00596258Phase 2Completed
- Sponsor
- Tigris Pharmaceuticals, Inc.
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Countries
- 1
01
Overview
A Phase 2 trial of sivifene in cervical intraepithelial neoplasia (CIN), sponsored by Tigris Pharmaceuticals, Inc.. Started Nov 2007; status: completed.
02
Drugs
sivifene
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00596258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596258.